Recombinant activated Factor VII (rFVIIa) can be used to control hemorrhage in a patient with Factor VIII or IX inhibitors. These inhibitors usually occur in patients with hemophilia, but occasionally may be encountered as an autoantibody.

To read more or access our algorithms and calculators, please log in or register.